CONMED (NYSE:CNMD) Shares Jump 18.9% as Organic Growth and EPS Offset Revenue Miss
CONMED Q3 2026 revenue missed consensus, but adjusted EPS beat; organic sales rose 6.7% and shares jumped 18.9% after hours on profitability.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill